• 1. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 2. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 5. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Tyrosine and derivatives

Exploring the Properties and Applications of (S)-3,4-Dihydroxyphenylalanine (CAS No. 40332-26-1)

(S)-3,4-Dihydroxyphenylalanine, commonly referred to as L-DOPA or levodopa, is a naturally occurring amino acid precursor to neurotransmitters such as dopamine, norepinephrine, and epinephrine. With the CAS number 40332-26-1, this compound has garnered significant attention in both scientific research and clinical applications due to its critical role in neurological functions. The (S)-enantiomer is particularly notable for its bioactivity, distinguishing it from its (R)-counterpart.

In recent years, the interest in L-DOPA has surged, driven by its therapeutic potential in managing Parkinson's disease, a neurodegenerative disorder affecting millions worldwide. Patients and researchers alike frequently search for "natural sources of L-DOPA" or "L-DOPA supplements for Parkinson's," reflecting the growing demand for alternative treatments. Mucuna pruriens, a tropical legume, is one such natural source rich in (S)-3,4-dihydroxyphenylalanine, making it a popular topic in holistic health circles.

The biochemical pathway of (S)-3,4-Dihydroxyphenylalanine involves its conversion to dopamine via the enzyme aromatic L-amino acid decarboxylase. This process is crucial for maintaining motor control and cognitive functions, which explains why "how L-DOPA works in the brain" is a frequently searched query. Additionally, the compound's ability to cross the blood-brain barrier sets it apart from dopamine itself, making it a cornerstone in neurological therapeutics.

Beyond its medical applications, (S)-3,4-Dihydroxyphenylalanine is also studied for its antioxidant properties. Researchers are investigating its potential in combating oxidative stress, a key factor in aging and chronic diseases. Searches like "L-DOPA antioxidant benefits" highlight public interest in its broader health implications. Moreover, its role in plant physiology, particularly in stress responses and pigment synthesis, adds another layer to its scientific relevance.

The synthesis of (S)-3,4-Dihydroxyphenylalanine has evolved over the years, with advancements in enzymatic and chemical methods improving yield and purity. Queries such as "how to synthesize L-DOPA in the lab" or "industrial production of levodopa" underscore the technical curiosity surrounding its manufacture. Innovations in biocatalysis and green chemistry are further optimizing its production, aligning with global sustainability goals.

In the realm of supplements and nutraceuticals, (S)-3,4-Dihydroxyphenylalanine is often marketed for its purported cognitive and mood-enhancing effects. However, consumers are increasingly searching for "L-DOPA side effects" and "safe dosage of L-DOPA," emphasizing the need for evidence-based information. Clinicians caution against unsupervised use due to potential adverse effects like dyskinesia or cardiovascular issues, reinforcing the importance of medical guidance.

Looking ahead, the future of (S)-3,4-Dihydroxyphenylalanine research lies in personalized medicine. With queries like "L-DOPA and genetic testing" gaining traction, scientists are exploring how individual genetic variations affect response to therapy. This aligns with the broader trend of precision medicine, where treatments are tailored to patients' unique biological profiles. Such advancements could revolutionize the management of neurological disorders and enhance quality of life for affected individuals.

In summary, (S)-3,4-Dihydroxyphenylalanine (CAS No. 40332-26-1) remains a pivotal compound in both science and medicine. From its foundational role in neurotransmitter synthesis to its expanding applications in health and wellness, it continues to captivate researchers and consumers alike. As interest grows in topics like "natural alternatives to L-DOPA" and "innovative delivery systems for Parkinson's treatment," this amino acid derivative will undoubtedly remain at the forefront of biomedical innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)